Latest Equity Incentive Plans News

Page 1 of 1
Austin Metals has appointed seasoned mining executive Michael Moore as Managing Director to spearhead exploration at its flagship Austin Gold Project in Western Australia.
Maxwell Dee
Maxwell Dee
2 Dec 2025
Ionic Rare Earths Limited secured shareholder approval on all resolutions at its 2025 Annual General Meeting, including director election, share consolidation, and capital raising measures.
Maxwell Dee
Maxwell Dee
28 Nov 2025
Australis Oil and Gas has struck two pivotal deals to advance its Tuscaloosa Marine Shale assets, securing a major US development partner and monetizing producing wells to strengthen its balance sheet.
Maxwell Dee
Maxwell Dee
27 Nov 2025
Frontier Digital Ventures announces key leadership changes with Patrick Grove stepping in as Executive Chairman and a planned CEO transition by November 2025.
Sophie Babbage
Sophie Babbage
25 Sept 2025
Camplify Holdings has responded to ASX concerns over a delayed director interest notice, revealing internal process failures and promising tighter compliance measures.
Sophie Babbage
Sophie Babbage
12 Sept 2025
Uscom Limited reported a 25% decline in revenue to $3.16 million and a 59% increase in net loss to $3.3 million for FY25, reflecting significant global headwinds. Despite setbacks, the company advanced new product approvals and secured funding to navigate ongoing challenges.
Ada Torres
Ada Torres
29 Aug 2025
Clarity Pharmaceuticals reported a $64.3 million loss for FY2025 alongside significant clinical progress and a $203.6 million placement to fund its radiopharmaceutical pipeline expansion.
Ada Torres
Ada Torres
28 Aug 2025
GBM Resources has appointed Daniel Hastings as its new CEO, bringing 25 years of global mining expertise to drive strategic growth and operational excellence.
Maxwell Dee
Maxwell Dee
11 Aug 2025
Yancoal Australia Ltd reported robust 2024 financial results and outlined key corporate governance actions at its 2025 Annual General Meeting, reinforcing its position as a leading coal producer amid market challenges.
Maxwell Dee
Maxwell Dee
28 May 2025
Neuren Pharmaceuticals has approved a significant long-term equity incentive plan tied to critical clinical and regulatory milestones for its drug candidate NNZ-2591, reinforcing management’s commitment to shareholder value.
Ada Torres
Ada Torres
23 May 2025
Anteris Technologies Global Corp. has filed an amended 10-K to disclose comprehensive governance, executive pay, and related party transactions for fiscal 2024, completing its annual SEC reporting obligations.
Ada Torres
Ada Torres
30 Apr 2025